Overview

A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow

Status:
Completed

Trial end date:
2007-07-01

Target enrollment:

Participant gender:

Summary

It is known that several common eye diseases are associated with ocular perfusion abnormalities. Moxaverine is used in the therapy of perfusion abnormalities in the brain, the heart and the extremities because of its direct vasodilatory effects. The present study seeked to investigate whether moxaverine alters ocular blood flow in healthy volunteers after intravenous administration.

Phase:

Phase 2

Details

Lead Sponsor:

Medical University of Vienna

Treatments:

Moxaverine
Papaverine